Insider Transactions in Q2 2021 at Harpoon Therapeutics, Inc. (HARP)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 02
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
25,118
-0.4%
|
$502,360
$20.5 P/Share
|
|
Jun 01
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
18,491
-0.29%
|
$369,820
$20.44 P/Share
|
|
May 28
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
13,885
-0.07%
|
$291,585
$21.8 P/Share
|
|
May 27
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
13,961
-0.22%
|
$279,220
$20.26 P/Share
|
|
May 26
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
3,198
-0.05%
|
$63,960
$20.04 P/Share
|
|
May 24
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
5,000
-0.08%
|
$100,000
$20.12 P/Share
|
|
May 21
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,907
-0.17%
|
$218,140
$20.21 P/Share
|
|
May 20
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
11,713
-0.18%
|
$234,260
$20.34 P/Share
|
|
May 19
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
17,833
-0.28%
|
$356,660
$20.39 P/Share
|
|
May 18
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
18,402
-0.28%
|
$368,040
$20.67 P/Share
|
|
May 17
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
4,666
-0.07%
|
$93,320
$20.07 P/Share
|
|
May 14
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
6,900
-0.11%
|
$138,000
$20.04 P/Share
|
|
May 13
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
4,855
-0.07%
|
$97,100
$20.06 P/Share
|
|
May 12
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
29,684
-0.46%
|
$593,680
$20.53 P/Share
|
|
May 11
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
21,445
-0.16%
|
$450,345
$21.24 P/Share
|
|
May 10
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
17,133
-0.13%
|
$376,926
$22.12 P/Share
|
|
May 05
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,172
-0.08%
|
$223,784
$22.81 P/Share
|
|
May 04
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
29,730
-0.23%
|
$683,790
$23.18 P/Share
|
|
May 03
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
30,766
-0.23%
|
$707,618
$23.24 P/Share
|
|
Apr 30
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
268,023
-3.89%
|
$5,896,506
$22.35 P/Share
|
|
Apr 29
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
67,292
-0.48%
|
$1,480,424
$22.28 P/Share
|
|
Apr 28
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
51,022
-0.36%
|
$1,071,462
$21.83 P/Share
|
|
Apr 27
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
11,829
-0.08%
|
$248,409
$21.13 P/Share
|
|
Apr 21
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
8,972
-0.06%
|
$170,468
$19.21 P/Share
|
|
Apr 20
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
22,249
-0.16%
|
$400,482
$18.9 P/Share
|
|
Apr 19
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,056
-0.07%
|
$191,064
$19.69 P/Share
|
|
Apr 16
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
5,847
-0.04%
|
$116,940
$20.19 P/Share
|
|
Apr 15
2021
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect |
1,052
-0.03%
|
$21,040
$20.49 P/Share
|
|
Apr 15
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
8,696
-0.12%
|
$173,920
$20.49 P/Share
|
|
Apr 14
2021
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect |
1,671
-0.03%
|
$33,420
$20.45 P/Share
|
|
Apr 14
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
13,806
-0.1%
|
$276,120
$20.45 P/Share
|
|
Apr 13
2021
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect |
1,943
-0.03%
|
$36,917
$19.72 P/Share
|
|
Apr 13
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
16,054
-0.11%
|
$305,026
$19.72 P/Share
|
|
Apr 12
2021
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect |
2,496
-0.03%
|
$52,416
$21.64 P/Share
|
|
Apr 12
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
20,628
-0.1%
|
$433,188
$21.64 P/Share
|
|
Apr 09
2021
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect |
10,300
-0.32%
|
$236,900
$23.67 P/Share
|
|
Apr 09
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,300
-0.14%
|
$236,900
$23.67 P/Share
|
|
Apr 01
2021
|
Holger Wesche Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-8.03%
|
$200,000
$20.78 P/Share
|
|
Apr 01
2021
|
Holger Wesche Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+7.26%
|
$0
$0.6 P/Share
|